Market Cap | 2.11B | P/E | - | EPS this Y | 24.00% | Ern Qtrly Grth | - |
Income | -31.6M | Forward P/E | 242.86 | EPS next Y | 63.20% | 50D Avg Chg | -11.00% |
Sales | 169.6M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -19.00% |
Dividend | N/A | Price/Book | 4.20 | EPS next 5Y | - | 52W High Chg | -36.00% |
Recommedations | 3.00 | Quick Ratio | 3.37 | Shares Outstanding | 124.34M | 52W Low Chg | 41.00% |
Insider Own | 66.62% | ROA | -5.83% | Shares Float | 40.67M | Beta | 0.50 |
Inst Own | 34.60% | ROE | -6.92% | Shares Shorted/Prior | 2.32M/1.67M | Price | 17.00 |
Gross Margin | 67.49% | Profit Margin | -18.63% | Avg. Volume | 109,659 | Target Price | 26.00 |
Oper. Margin | -9.23% | Earnings Date | May 9 | Volume | 60,119 | Change | -5.50% |
Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
Morgan Stanley | Equal-Weight | Mar 26, 24 |
Canaccord Genuity | Hold | Mar 26, 24 |
Morgan Stanley | Equal-Weight | Oct 24, 23 |
Scotiabank | Sector Perform | Oct 18, 23 |
Morgan Stanley | Equal-Weight | Aug 10, 23 |
Morgan Stanley | Equal-Weight | May 15, 23 |
Goldman Sachs | Neutral | Feb 23, 23 |
Morgan Stanley | Equal-Weight | Feb 22, 23 |
Goldman Sachs | Neutral | Feb 22, 23 |